238 related articles for article (PubMed ID: 32580694)
1. Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine - temporal relation to bleeding and hormone withdrawal: a prospective diary-based study.
Merki-Feld GS; Caveng N; Speiermann G; MacGregor EA
J Headache Pain; 2020 Jun; 21(1):81. PubMed ID: 32580694
[TBL] [Abstract][Full Text] [Related]
2. Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.
Merki-Feld GS; Epple G; Caveng N; Imthurn B; Seifert B; Sandor P; Gantenbein AR
J Headache Pain; 2017 Aug; 18(1):91. PubMed ID: 28842849
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study.
Merki-Feld GS; Sandor PS; Nappi RE; Pohl H; Schankin C
Acta Neurol Belg; 2022 Apr; 122(2):401-409. PubMed ID: 33928470
[TBL] [Abstract][Full Text] [Related]
4. Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?
Tiranini L; Cucinella L; Martella S; Bosoni D; Martini E; Nappi RE
Expert Rev Neurother; 2023 Apr; 23(4):377-388. PubMed ID: 37038655
[TBL] [Abstract][Full Text] [Related]
5. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
6. Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?
Merki-Feld GS; Imthurn B; Dubey R; Sándor PS; Gantenbein AR
J Obstet Gynaecol; 2017 Apr; 37(3):338-341. PubMed ID: 28129717
[TBL] [Abstract][Full Text] [Related]
7. Menstrual impact of contraception.
Stubblefield PG
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
[TBL] [Abstract][Full Text] [Related]
8. Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study.
De Icco R; Cucinella L; De Paoli I; Martella S; Sances G; Bitetto V; Sandrini G; Nappi G; Tassorelli C; Nappi RE
J Headache Pain; 2016 Dec; 17(1):70. PubMed ID: 27488685
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
10. Sex hormones and headache.
Silberstein SD; Merriam GR
J Pain Symptom Manage; 1993 Feb; 8(2):98-114. PubMed ID: 8492007
[TBL] [Abstract][Full Text] [Related]
11. Menstrual Migraines: Diagnosis, Evidence, and Treatment.
Olson AK; Hansen KA
S D Med; 2021 Dec; 74(12):570-575. PubMed ID: 35015948
[TBL] [Abstract][Full Text] [Related]
12. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen.
MacGregor EA; Frith A; Ellis J; Aspinall L; Hackshaw A
Neurology; 2006 Dec; 67(12):2154-8. PubMed ID: 16971700
[TBL] [Abstract][Full Text] [Related]
13. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Hamerlynck JV; Vollebregt JA; Doornebos CM; Muntendam P
Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054
[TBL] [Abstract][Full Text] [Related]
14. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.
MacGregor EA; Frith A; Ellis J; Aspinall L; Hackshaw A
Neurology; 2006 Dec; 67(12):2159-63. PubMed ID: 17190936
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
[TBL] [Abstract][Full Text] [Related]
16. Sex hormones and headache.
Silberstein SD
Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
[TBL] [Abstract][Full Text] [Related]
17. Extended and continuous combined contraceptive regimens for menstrual suppression.
Jacobson JC; Likis FE; Murphy PA
J Midwifery Womens Health; 2012; 57(6):585-592. PubMed ID: 23217068
[TBL] [Abstract][Full Text] [Related]
18. Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary.
van Casteren DS; Verhagen IE; van der Arend BWH; van Zwet EW; MaassenVanDenBrink A; Terwindt GM
Neurology; 2021 Oct; 97(17):e1661-e1671. PubMed ID: 34493613
[TBL] [Abstract][Full Text] [Related]
19. Menstrual Migraine and Treatment Options: Review.
Maasumi K; Tepper SJ; Kriegler JS
Headache; 2017 Feb; 57(2):194-208. PubMed ID: 27910087
[TBL] [Abstract][Full Text] [Related]
20. Migraine Management During Menstruation and Menopause.
MacGregor EA
Continuum (Minneap Minn); 2015 Aug; 21(4 Headache):990-1003. PubMed ID: 26252586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
